An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

Sharma, Praveen; Kumar, Ashish; C. Shrama, Brajesh; Kumar Sarin, Shiv

doi:10.1111/j.1572-0241.2008.01828.x

Public

An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

Published in The American Journal of Gastroenterology • Jun 13, 2008

Authors:

Praveen Sharma

Ashish Kumar

Brajesh C. Shrama

Abstract

BACKGROUND AND AIMS: Hepatorenal syndrome (HRS) is characterized by functional renal failure in end-stage liver disease. Terlipressin is the drug of choice for treating type 1 HRS (HRS-1). It is expensive and often not readily available. We, in an open label, randomized, pilot trial, compared the ef...

Subject

Terlipressin

Medicine

Hepatorenal syndrome

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!